Clinical Research Directory
Browse clinical research sites, groups, and studies.
Adherence Intervention in Patients With Metastatic Breast Cancer
Sponsor: Columbia University
Summary
To evaluate the preliminary efficacy of a multicomponent adherence intervention focused on enhancing digital equity and pharmaco-equity among nonadherent patients with metastatic breast cancer (MBC) and cardiovascular disease (CVD) risk factors on endocrine therapy (ET), CDK4/6 inhibitor (CDK 4/6i), and CVD medications. To assess the acceptability and appropriateness of this intervention in patients with MBC and CVD risk factors through validated measures of implementation outcomes. To gain a deeper understanding of the impact of social determinants of health (SDOH) on medication nonadherence through semi-structured interviews with a subset of study participants.
Official title: P50 Supplement: Improving Medications Adherence Equitably Among Patients With Metastatic Breast Cancer and Cardiovascular Disease
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
INTERVENTIONAL
Enrollment
35
Start Date
2024-04-12
Completion Date
2026-12-10
Last Updated
2026-07-28
Healthy Volunteers
No
Conditions
Interventions
Multicomponent Adherence Intervention
multi-part intervention to reduce barriers to medication use
Locations (1)
Columbia University Medical Center
New York, New York, United States